查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球神经监测系统市场 - 2023-2030
市场调查报告书
商品编码
1345438

全球神经监测系统市场 - 2023-2030

Global Nerve Monitoring Systems Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

全球神经监测系统市场在 2022 年达到 14 亿美元，预计到 2030 年将达到 54 亿美元，2023-2030 年预测期间复合年增长率为 5.6%。

术中神经监测 (IOM) 使外科医生能够在外科手术过程中监测和控制神经的功能。当需要进行神经外科和脊柱手术时，需要使用先进的技术设备，这已成为治疗的标准。术中神经监测系统使外科医生能够识别、确认和监测运动神经功能，以帮助降低各种手术（包括耳鼻喉科和普通手术）期间神经损伤的风险。

此外，全球神经监测系统市场受到多种因素的推动，例如神经相关疾病病例的增加、人工智能等进步的增加、主要参与者产品发布的增加、与其他公司的合作和收购以及其他拥有重要关键参与者的公司，如美敦力(Medtronic)、Nuvasive、NihonKohden、CheckPoint Surgicals 等。

动力学

神经监测在创伤病例中的应用不断增加

在创伤病例中使用神经监测的增加是预测期内帮助市场增长的关键因素之一。使用术中神经监测（IONM）作为疤痕组织解剖的辅助手段被认为可以最大限度地降低神经损伤的风险。这些系统帮助外科医生了解神经的功能完整性，而且这些系统的使用确实在市场上有所增加。

例如，2021 年4 月，Penn Medicine 成立了Penn Nerve Center，该中心联合了跨学科的专家，为各种神经疾病提供专家诊断和尖端治疗，包括创伤性神经损伤、神经卡压、神经压迫和神经肿瘤。

神经监测系统的进步

神经监测系统的进步是帮助市场在预测期内增长的关键因素之一。这些进步有助于外科医生准确定位和监测神经，这确实减少了手术过程中对患者的伤害。神经监测系统已集成了多项进步，其中之一就是机器学习。机器学习模型的使用将提高神经监测的效率和可靠性。有各种机器学习模型，例如神经网络、人工神经网络、卷积神经网络等等。

例如，2022 年 3 月，韩国科学技术院 (KAIST) 的研究人员开发了一种读心系统，用于解码手臂运动期间大脑发出的神经信号。该系统使用脑电图（EEG）和皮质电图（ECoG）技术。

ECoG 主要用于寻找癫痫发作的潜在来源，这意味着电极针对不同患者放置在不同位置，并且可能不在大脑中检测感觉和运动信号的最佳区域。

为了克服这些问题，Jeong教授的团队开发了一种解码手臂运动期间ECoG神经信号的新方法。该系统基于用于分析和预测称为“迴声状态网络”的神经信号的机器学习系统和称为高斯分布的数学概率模型。

产品发布量增加

产品发布的增加是预测期内帮助市场增长的关键因素之一。例如，2021 年 6 月，专注于改善慢性疼痛患者疼痛缓解的医疗器械公司 NeuraLace Medical, Inc. 今天宣布，其 Axon Therapy 已获得 FDA 510(k) 批准，可用于非侵入性刺激周围神经并缓解慢性神经疼痛。

合作伙伴关係、扩张和收购等战略倡议也将带来显着的市场增长。

例如，2022 年 4 月，Assure Holdings Corp. 与 Conductive 签订了术中神经监测服务的集团采购协议（“GPO”）。该协议允许 Conductive 成员（包括 500 家医院和手术中心以及 50 多个卫生系统）利用 Assure 联合委员会认可的术中神经监测服务的特殊定价和预先协商条款。

医疗保健专业人员对神经监测的认识有限

神经监测设备变得更加复杂，需要广泛的设备知识。许多新的基础软件与神经监测设备集成，但由于缺乏对神经生理学监测的基本了解，误解和技术挑战可能会恶化。不发达国家或新兴国家需要更多的专业人员来有效地使用这些设备。

目录

第 1 章：方法和范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义和概述

第 3 章：执行摘要

  • 按产品类型分類的片段
  • 技术片段
  • 按应用程序片段
  • 最终用户的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 神经监测在创伤病例中的应用不断增加
      • 神经监测系统的进步
      • 产品发布量增加
      • 合作伙伴关係、扩张和收购等战略倡议也将带来市场的显着增长
    • 限制
      • 医疗保健专业人员对神经监测的认识有限
    • 机会
      • 神经相关疾病病例增加
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商战略倡议
  • 结论

第 7 章：按产品类型

  • 显示器
  • 刺激装置
  • 神经监测电极
  • 探头

第 8 章：按技术

  • 诱发电位(EP)
  • 肌电图（EMG）
  • 脑电图（EEG）
  • 皮质电图（ECOG）

第 9 章：按应用

  • 神经外科
  • 脊柱外科
  • 耳鼻喉科手术
  • 心血管应用
  • 其他应用

第 10 章：最终用户

  • 医院
  • 手术中心
  • 门诊手术中心
  • 其他的

第 11 章：按地区

  • 北美
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 12 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 13 章：公司简介

  • Medtronic
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Nuvasive
  • NihonKohden
  • CheckPoint Surgicals
  • Natus
  • Inomed
  • Magstim
  • Neurowave Systems
  • Axontronic
  • Xavant Technologies

第 14 章：附录

简介目录
Product Code: MD6788

Overview

Global Nerve Monitoring Systems Market reached US$ 1.4 billion in 2022 and is expected to reach US$ 5.4 billion by 2030, growing with a CAGR of 5.6% during the forecast period 2023-2030.

Intraoperative nerve monitoring (IOM) enables surgeons to monitor and control the function of the nerves during a surgical procedure. When neurosurgery and spinal surgery are required, this entails the use of advanced technology equipment that has become the standard of treatment. Intraoperative nerve monitoring systems enable surgeons to identify, confirm, and monitor motor nerve function to help reduce the risk of nerve damage during various procedures, including ENT and general surgeries.

Furthermore, the global nerve monitoring systems market is driven by various factors like an increase in the cases of nerve-related disorders, a rise in advancements like the inclusion of AI, a rise in product launches by key players, collaboration and acquisition with other companies and others having significant key players like Medtronic, Nuvasive, NihonKohden, CheckPoint Surgicals and others.

Dynamics

Rising Use of Nerve Monitoring in Trauma Cases

The rise in the use of nerve monitoring in trauma cases is one of the key factors that helps the market to grow during the forecast period. The use of intraoperative nerve monitoring (IONM) as an aid in dissection of the scar tissue is believed to minimize the risk of nerve injury. These systems help surgeons to know the functional integrity of nerves and indeed the use of these systems rises in the market.

For instance, in April 2021 Penn Medicine launched the Penn Nerve Center, which unites experts across disciplines to offer expert diagnosis and cutting-edge treatment for a wide range of nerve conditions including traumatic nerve injuries, nerve entrapment, nerve compression, and nerve tumours.

Advancements in Nerve Monitoring Systems

Advancements in Nerve Monitoring Systems are one of the key factors that help the market to grow during the forecast period. These advancements help the surgeons to accurately locate and monitor the nerves which indeed reduces the damage to the patient during the surgical procedures. Several advancements have been integrated into the nerve monitoring systems one of them was Machine learning. The efficiency and reliability of nerve monitoring will be enhanced with the use of ML models. There are various machine learning models like Neural Networks, Artificial Neural Networks, Convolutional Neural Networks and many more.

For instance, in March 2022, Researchers from the Korea Advanced Institute of Science and Technology (KAIST) developed a mind-reading system for decoding neural signals from the brain during arm movement. This system uses electroencephalography (EEG) and electrocorticography (ECoG) techniques.

The ECoG is primarily used to find potential sources of epileptic seizures, meaning the electrodes are placed in different locations for different patients and may not be in the optimal regions of the brain for detecting sensory and movement signals.

To overcome these problems, Professor Jeong's team developed a new method for decoding ECoG neural signals during arm movement. The system is based on a machine-learning system for analyzing and predicting neural signals called an 'echo-state network' and a mathematical probability model called the Gaussian distribution.

Rise In the Product Launches

Rise in the product launches is one of the key factors that helps the market to grow during the forecast period. For instance, in June 2021, NeuraLace Medical, Inc., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today that it has received FDA 510(k) clearance for Axon Therapy to non-invasively stimulate peripheral nerves and provide chronic nerve pain relief.

Strategic Initiatives Such as Partnerships, Expansions, And Acquisitions Will Also Lead to Significant Market Growth.

For instance, in April 2022, Assure Holdings Corp. entered into a group purchasing agreement ("GPO") for intraoperative neuromonitoring services with Conductive. The agreement allows Conductive members, which includes 500 hospitals and surgery centers and more than 50 health systems, to take advantage of special pricing and pre-negotiated terms for Assure's Joint Commission-accredited intraoperative neuromonitoring services.

Limited Awareness About Nerve Monitoring Among Healthcare Professionals

Nerve monitoring devices become more complex, requiring extensive device knowledge. Many new fundamental software is integrated with nerve monitoring devices, but misunderstandings and technical challenges may worsen due to a lack of fundamental understanding of neurophysiological monitoring. More professionals are needed in undeveloped or emerging countries to effectively use these devices.

Segment Analysis

The global nerve monitoring systems market is segmented based on product type, technology, application, end-user and region.

The Neurosurgery Segment From The Application Segment Accounted For Approximately 43.7% of Nerve Monitoring Systems Share

The neurosurgery segment from the application segment accounted for 43.7% and it is expected to be dominated during the forecast period. There is a growing burden of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, Huntington's disease, and motor neuron diseases, among others, in the older population across the world. Thus, this leads to progressive neural dysfunction and toxicities, increasing the demand for effective nerve modulation devices, thereby driving growth in the studied market. Thus, with the increasing geriatric population, the burden of neurological diseases may increase and boost the segment's growth during the forecast period.

For instance, according to Alzheimer's Association updated factsheet 2023 An estimated 6.7 million Americans age 65 and older are living with Alzheimer's dementia in 2023. Seventy-three percent are age 75 or older of the total U.S. population. About 1 in 9 people (10.8%) age 65 and older have Alzheimer's dementia. Hence Due to the increasing burden of Alzheimer's Disease, brain surgeries are expected to increase, creating the need for a nerve monitoring system over time.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to factors like these devices are majorly used in a variety of surgical disciplines, such as otolaryngology, spine surgery, and neurosurgery, FDA Clearance, real-time data from nerve monitoring equipment during surgeries increases surgical accuracy and lowers the chance of nerve injury. As technology is developing, monitoring systems have become more sophisticated and user-friendly, luring healthcare providers to invest in these solutions.

In addition, as these systems are essential for the diagnosis and management of such problems, the rising frequency of chronic neurological disorders, and an ageing population contribute to the revenue growth of the market in this region.

In April 2023, Neuspera Medical, a medical device company developing implantable devices for patients battling chronic illnesses, announced it received U.S. Food and Drug Administration (FDA) clearance for the next-generation Neuspera ultra-miniaturized system. The system is comprised of a micro-implant that delivers neurostimulation therapy through a wireless platform including a wearable transmitter and iPad-based clinician programmer.

Competitive Landscape

The major global players in the market include: Medtronic, Nuvasive, NihonKohden, CheckPoint Surgicals, Natus, Inomed, Magstim, Neurowave Systems, Axontronic, Xavant Technologies and among others.

COVID-19 Impact Analysis

COVID had a substantial impact on the global nerve monitoring systems market during the current pandemic COVID-19 is a newly widespread virus with a high infection rate many individuals have faced heart-related issues and brain which indeed resulted in some surgeries at peak stages hence due to the increased number of patients with limited hospital facilities in many parts of the world. Since need for Non-invasive monitoring of individuals with COVID-19 can help triage by monitoring at-risk persons and assessing the need for invasive monitoring modalities.

By Product Type

  • Monitors
  • Stimulation Devices
  • Nerve Monitoring Electrodes
  • Probes

By Technology

  • Evoked Potential(EP)
    • Somatosensory Evoked Potential (SSEP)
    • Motor Evoked Potential (MEP)
    • Visual Evoked Potential (VEP)
    • Brainstem Auditory Evoked Potential (BAEP)
  • Electromyography (EMG)
  • Electroencephalography (EEG)
  • Electrocorticography (ECOG)

By Application

  • Neurosurgery
  • Spine Surgery
  • ENT Surgery
  • Cardiovascular Applications
  • Other Applications

By End User

  • Hospitals
  • Surgical Centers
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In March 2021 Neurosign gained FDA clearance for the V4 4-channel and 8-channel nerve monitoring system and it is already being used on patients for nerve identification and preservation in the USA. Dr. Jeffson Chung, a surgeon and Assistant Professor of Otolaryngology, and Director of QI and Safety, at West Virginia University Hospital, recently used the V4 in successful thyroidectomy and facial nerve surgeries. For nerve identification and stimulation, Dr. Chung used the Neurosign Bipolar probe.
  • In October 2020 Medtronic plc the global leader in medical technology, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital nerve monitoring system, which enables physicians to identify, confirm, and monitor nerve function to help reduce the risk of nerve damage during head and neck surgery.1 The NIM Vital system uses proprietary technology to provide detailed intraoperative nerve condition data that informs surgical strategy,2 increases operative efficiency and precision,3 and helps protect patients' quality of life.

Why Purchase the Report?

  • To visualize the global nerve monitoring systems market segmentation based on product type, technology, application, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global nerve monitoring systems market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The Global Nerve Monitoring Systems Market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Use of Nerve Monitoring in Trauma Cases
      • 4.1.1.2. Advancements in Nerve Monitoring Systems
      • 4.1.1.3. Rise In the Product Launches
      • 4.1.1.4. Strategic Initiatives Such as Partnerships, Expansions, And Acquisitions Will Also Lead To Significant Market Growth
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Awareness About Nerve Monitoring Among Healthcare Professionals
    • 4.1.3. Opportunity
      • 4.1.3.1. Increase in the Cases of Nerve-Related Disorders
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Monitors*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Stimulation Devices
  • 7.4. Nerve monitoring Electrodes
  • 7.5. Probes

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Evoked Potential(EP)*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Electromyography (EMG)
  • 8.4. Electroencephalography (EEG)
  • 8.5. Electrocorticography (ECOG)

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Neurosurgery *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Spine Surgery
  • 9.4. ENT Surgery
  • 9.5. Cardiovascular Applications
  • 9.6. Other Applications

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Surgical Centers
  • 10.4. Ambulatory Surgical Centers
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Medtronic *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Nuvasive
  • 13.3. NihonKohden
  • 13.4. CheckPoint Surgicals
  • 13.5. Natus
  • 13.6. Inomed
  • 13.7. Magstim
  • 13.8. Neurowave Systems
  • 13.9. Axontronic
  • 13.10. Xavant Technologies

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us